To Top

Content Filter


896 Articles available
Research

Cancer Research as Art

PR-M12-17-NI-003
Oncology

Holiday Program Brings Hope Home to Lung Cancer Patients

PR-M12-17-NI-002
Over-the-Counter

Men in the UK Will Be Able to Buy Viagra Over the Counter Next May

PAO-M12-17-NI-013
Abuse Deterrence

Generic Firms Developing Opioids with Abuse-Deterrent Properties Have New FDA Guidance to Follow

PAO-M12-17-NI-012
Packaging

Vetter Begins Construction of Packaging Facility Expansion

PAO-M12-17-NI-011
Immuno-oncology

Genentech and Biothera to Assess Combination Cancer Therapy

PAO-M12-17-NI-010
Innovation

University of Michigan Innovates with Kevlar Cartilage

PAO-M12-17-NI-009
Drug Development

U.S. Patient Receives Kite’s Yescarta CART-T Therapy

PAO-M12-17-NI-008
Biosimilars

First Biosimilar to Treat Breast and Stomach Cancers Approved

PAO-M12-17-NI-007
Medical Application

FDA Clears KardiaBand Apple Watch Heart Monitoring App

PAO-M12-17-NI-006
Mergers & Acquistions

Five Critical Considerations for Pharmaceutical M&A

PAO-M12-17-Cl-001
Recognition

Vetter receives Corporate Health Award’s recognition of excellence

PR-M12-17-NI-001
Strategic Partnership

AstraZeneca Launches Strategic Joint Venture in China

PAO-M12-17-NI-005
Clinical Trial

Zika Vaccine Candidate Enters Phase I Trial

PAO-M12-17-NI-008
Strategic Partnership

Russia’s BIOCAD to Manufacture Biosimilars in North Africa

PAO-M12-17-NI-007
Cell and Gene Therapy

Brammer Bio Completes Renovations at Manufacturing Site in Massachusetts

PAO-M12-17-NI-006
Regenerative Medicine

International Society for Cellular Therapy Supports New FDA Policy Framework for Regenerative Medicine

PAO-M12-17-NI-004
Drug Development

Thermo Fisher Scientific’s Patheon Division to Manufacture Nasal Formulation for Evoke Pharma

PAO-M12-17-NI-003
Strategic Partnership

New Collaboration Targets the Development of Oligonucleotides

PAO-M12-17-NI-002
PAO-M12-17-NI-001

Amerisource Bergen Expands in the US with Acquisition of H.D. Smith

PAO-M12-17-NI-001
Innovation

New Ferring and Aché Laboratórios Farmacêuticos Facility Opens to Optimise Drug Delivery Using Nanotechnology

PR-M11-17-NI-018
Business

Bio-Rad Authorizes New $250 Million Share Repurchase Program

PR-M11-17-NI-017
Acquisition

Pharmaterials Acquired by Quotient Sciences

PAO-M11-17-NI-051
Research

Study Finds Less Teflon in Environment Leads to Less Brain Damage

PAO-M11-17-NI-052
Innovation

Single-Pill, HIV-1 Combination Therapy Approved

PAO-M11-17-NI-050
Discovery

Boehringer Ingelheim and HitGen Enter Drug Discovery Collaboration

PAO-M11-17-NI-049
FDA Approval

Advanced Follicular Lymphoma Treatment Approved

PAO-M11-17-NI-048
Expansion

Fresenius Kabi Plans $100 Million North Carolina Expansion

PAO-M11-17-NI-047
//Fix for text overflow in cards